Introduction
Leigh syndrome (LS) is the most frequent pediatric mitochondrial disorder, leading to defective mitochondrial energy metabolism. LS affects 1 in 40,000 births 1 , although adult onset has also been described 2 . Mutations in more than 75 genes have been described to cause LS 3 . To date, no effective treatment or cure exists. Clinically, albeit highly variable, LS symptoms usually include failure to thrive, hypotonia, rigidity, seizures, ataxia, lactic acidosis, encephalopathy and premature death 1, 3, 4 . LS is characterized by restricted anatomical and cellular specificity 5 , a common feature shared by mitochondrial diseases, affecting high energy-requiring tissues such as muscle and brain 6 . Pathologically, LS is characterized by the presence of bilateral symmetrical lesions predominantly in the brainstem and basal ganglia 5 . Neuronal damage is responsible for most of the fatal symptoms, including respiratory failure and seizures 7 . However, the identity of the affected cellular populations and the molecular determinants of neuronal vulnerability have not been adequately elucidated, representing a challenge for the development of efficient treatments.
Mutations affecting the NDUFS4 subunit of mitochondrial Complex I, a key structural component for the assembly, stability and activity of the complex 8 , are commonly associated with a severe, early-onset LS phenotype 9 . Although a late-onset case of LS has been recently reported 10 , prognosis is usually poor and most of the patients die in early childhood 4 .
Animals with a global deletion of Ndufs4 (Ndufs4KO mice) develop a fatal encephalomyopathy which recapitulates the classical signs of LS, including motor alterations, respiratory deficits, epilepsy and premature death 11, 12 . Behavioral and neuropathological characterization of Ndufs4KO mice revealed the pivotal role of the dorsal brainstem, particularly the vestibular nucleus (VN), in disease manifestation and progression 13 . However, the genetic identity of the neuronal populations and circuitries involved in the plethora of symptoms observed
have not yet been identified.
Here, we describe the contribution of genetically defined, discrete neuronal populations to the fatal phenotype of Ndufs4KO mice. To that end, we generated three mouse lines using a conditional genetic approach that selectively inactivates Ndufs4 in glutamatergic (Vglut2-expressing), GABAergic (Gad2-expressing) or cholinergic (ChAT-expressing) neurons. The results reveal distinct, lethal phenotypes for the glutamatergic and GABAergic neuronal populations.
Results
Reduced lifespan and body weight in cell type-specific conditional Ndufs4KO mice.
To dissect the neuronal cell types contributing to the neuropathology observed in Ndufs4KO mice [11] [12] [13] , we generated three mouse lines lacking Ndufs4 selectively in glutamatergic (expressing Vglut2), GABAergic or cholinergic neurons. We did this by crossing Ndufs4 exon2-floxed mice with Cre-driver lines of mice expressing either Slc17a6-Cre, Gad2-Cre or Chat-Cre as described in Figure 1A and Supplementary Figure S1A ; the affected mice are referred to here as:
Vglut2:Ndufs4cKO, Gad2:Ndufs4cKO or ChAT:Ndufs4cKO mice and their respective controls are Vglut2:Ndufs4cCT, Gad2:Ndufs4cCT or ChAT:Ndufs4cCT.
Ndusf4 gene inactivation in glutamatergic or GABAergic neurons of both male and female mice resulted in failure to thrive and premature death ( Figure 1B-F) ; however, there was no effect on survival, body weight, or motor function when Ndufs4 expression was abolished in cholinergic
neurons (Supplemental Figures S1B-C). Selective deletion of Ndufs4 in glutamatergic or
GABAergic neurons was confirmed by western blot analysis of NDUFS4 levels in brain areas where Vglut2 or Gad2 are preferentially expressed 14 (Supplemental Figure S2A ).
Vglut2:Ndufs4cKO mice had a median lifespan of 67 days with a mortality rate of 90% at postnatal day (P) 128. Similarly, Gad2:Ndufs4cKO mice had a median lifespan of 60 days (90% mortality at P70) ( Figure 1B ). This premature death was preceded by weight loss in male and female mice of both genotypes ( Figure 1C -F). At 7 weeks of age for females and 9 weeks of age for males, Vglut2:Ndufs4cKO mice stopped gaining weight, which resulted in an overall reduction in body weight when compared to age-matched controls ( Figure 1C-D) . Similarly, male and female Gad2:Ndufs4cKO mice started to show reduced body weight 2-3 weeks before manifesting a sudden unexpected death ( Figure 1E -F). Both Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice were also significantly smaller than their littermate controls ( Figure 1G -H). This lack of weight gain and reduced size appeared to be due to decreased food intake in both genotypes ( Figure 1I-J) ; however, this was not significantly different when food consumption was normalized to body weight ( Figure S2B ).
Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice manifest clinically distinct phenotypes
The reduced lifespan and decreased body weight observed in both Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice were the result of two prominently different clinical presentations.
Gad2:Ndufs4cKO mice were, for the most part, phenotypically indistinguishable from controls, without any overt clinical alteration beyond a reduced growth rate for a few weeks prior to a sudden premature death. On the other hand, Vglut2:Ndufs4cKO mice manifested progressive motor and respiratory deterioration with most of the clinical signs visibly apparent (Table 1) .
Vglut2:Ndufs4cKO mice presented body tremor and a decline in balance as early as at 5
weeks (early stage of the disease), which dramatically worsened as the disease progressed. In a mid-stage of the disease, mice increased body tremor and showed a prominent decline in balance and motor coordination. Subsequently, animals started exhibiting ataxia and a progressive loss of the righting and hindlimb extension reflexes (Supplemental Figure S3A) . At a late stage of the disease, these mice showed increased tremor, were completely docile and hypotonic, and would not explore new environments. Animals also had difficulty maintaining a regular breathing pattern at an early stage of the disease. These breathing abnormalities worsened as the disease progressed with mice presenting noticeably shorter and deeper respirations at advanced stages of the disease (Supplemental Video S1). Furthermore, at a late stage of the disease, about 40% of Vglut2:Ndufs4cKO developed hindlimb dragging and eventually hindlimb paralysis. We observed increased glial reactivity but no neuronal loss in the spinal cord of these mice when compared to Vglut2:Ndufs4cCT mice, which was determined by immunoblot analysis of spinal cord lysates from Vglut2:Ndufs4cCT and Vglut2:Ndufs4cKO mice using antibodies against GFAP (glial fibrillary acidic protein), Iba-1 (ionized calcium-binding adapter molecule 1) and NSE (neuronal specific enolase) (Supplemental Figure S3B ). This glial reactivity was further confirmed by immunofluorescence analysis using anti-GFAP and anti-Iba-1 antibodies in the spinal cords of the Vglut2:Ndufs4cKO mice that exhibited hindlimb dragging (Supplemental Figure S3C , top panels).
However, no signs of demyelination or immune cell infiltration were observed (Supplemental Figure S3C , mid and bottom panels).
Neuronal identity defines distinct neuroinflammatory patterns after Ndufs4 deletion
LS is characterized by symmetrical brain lesions and neuroinflammation in select nuclei, predominantly brainstem and/or basal ganglia 5 . Accordingly, Ndufs4-deficient mice present overt lesions in brainstem (namely vestibular nucleus (VN), cerebellar fastigial nucleus (FN) and inferior olive (IO)), olfactory bulb and basal ganglia 11, 13, 15 . To define the contribution of Ndufs4 deficiency in either excitatory or inhibitory neurons to the overall neuroinflammatory phenotype and identify the specific brain areas with exacerbated astroglial and microglial reactivity, we performed immunofluorescence analysis using anti-GFAP and anti-Iba1 antibodies on brain sections of Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice, and their respective controls (Figures 2A-B) .
Analysis of these sections showed marked glial reactivity in VN, IO and FN ( Figure 2A ) in Vglut2:Ndufs4cKO mice, recapitulating most of the neuroinflammatory profile described for the global Ndufs4KO mice 11 . In contrast, Gad2:Ndufs4cKO mice presented a more restricted glial reactivity pattern, including marked microglial and astroglial reactivity in primarily GABAergic nuclei such as the external globus pallidus (GPe) in the basal ganglia and the substantia nigra pars reticulata (SNr) ( Figure 2B ), without affecting neighboring non-GABAergic areas like the dopaminergic substantia nigra pars compacta (SNc) (Supplemental Figure S4A ). Other prominently GABAergic areas such as the olfactory bulb also showed increased immunoreactivity for GFAP and Iba-1 in Gad2:Ndufs4cKO mice when compared to control mice ( Figure 2B ). In a percentage of Gad2:Ndufs4cKO mice, prominent microglial reactivity with Purkinje neuron loss (as assessed by calbindin staining) was also observed in the cerebellar vermis and flocculus (Supplemental Figure S4B ).
The extensive neuroinflammation present in the brainstem of Vglut2:Ndufs4cKO mice allowed us to further define this inflammatory phenotype using whole-tissue transcriptional profiling. Gene expression analysis in the brainstem of Vglut2:Ndufs4cKO mice using Illumina (Figure 3 ).
Starting at P40, and concurring with the onset of clinical signs, Vglut2:Ndufs4cKO mice showed impaired rotarod performance when compared to control littermates ( Figure 3A ). While control mice maintained rotarod performance, Vglut2:Ndufs4cKO mice failed to properly execute the task, presenting a progressive decline in motor coordination, in line with the clinical phenotype.
Conversely, and in agreement with the lack of apparent clinical signs, no differences in rotarod performance were observed in Gad2:Ndufs4cKO mice compared to control littermates ( Figure 3B ). Respiratory abnormalities are frequently associated with disease mortality in LS patients and global Ndufs4KO mice 5, 13, 19 . To provide insight into the genetic identity of the neurons responsible for this respiratory phenotype, we assessed respiratory function by unrestrained whole-body plethysmography in awake Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice. Vglut2:Ndufs4cKO mice exhibited erratic plethysmographic recordings ( Figure 4A ). In these mice, the frequency of respiration (fR) was markedly reduced at a mid-stage of the disease and worsened as disease progressed ( Figure 4C ). In addition, significant differences were also seen in the volume of air inspired by the animal during one breath (tidal volume, VT). VT was increased in Vglut2:Ndufs4cKO mice at a mid-stage of the disease and became significantly larger than in Vglut2:Ndufs4cCT at late disease stages ( Figure 4D ). In contrast, Gad2:Ndufs4cKO mice did not exhibit irregular plethysmographic traces and had breathing patterns (fR and VT) that did not differ from controls (Figures 4B and 4E-F). These data reveal that the motor impairment and respiratory deficits observed in the Ndufs4KO mouse are mediated by Vglut2-expressing excitatory neuronal populations.
We have shown that neuronal inactivation of Ndufs4 in the VN promotes breathing abnormalities 13 . This observation, along with the extensive neuroinflammation observed in the VN of Vglut2:Ndufs4cKO mice, prompted us to assess the activity of Vglut2-expressing neurons in the Figure S7A ). Drug-treated mice showed a median survival of 63 and 66 days, respectively, which was not statistically significant when compared to the median lifespan of vehicle-treated mice (59 days). Abnormal activation of the mechanistic target of rapamycin (mTOR) pathway has been involved in epileptic episodes, and its inhibition suppresses seizures in otherwise drug-resistant epilepsy [26] [27] [28] .
Ndufs4
deletion leads to elevated mTOR signaling in mice and its inhibition with rapamycin (8 mg/kg) extends lifespan in Ndufs4KO mice 29 . Hence, we administered rapamycin (8 mg/kg; 5 days/week) to Gad2:Ndufs4cKO mice. This treatment significantly inhibited mTOR activity as assessed by the phosphorylation status of its downstream target ribosomal protein S6 (Supplemental Figure S7B- C). However, no effect on survival was observed in rapamycin-treated Gad2:Ndufs4cKO mice compared to vehicle-treated mice (59 days median survival for both groups) (Supplemental Figure   S7A ).
Discussion
Neuronal vulnerability is one of the hallmarks of Leigh Syndrome. However, the restricted anatomical distribution of brain lesions indicates a clear gradation in neuronal susceptibility to LScausing mutations. Specific neuronal populations in affected regions, such as brainstem or basal ganglia, are highly vulnerable to mitochondrial dysfunction and may underlie the plethora of neurological signs observed in LS. The scarcity and high variability of patients has limited our knowledge on the genetic identity and relative contribution of the affected neuronal populations to the phenotype; thus, a model system with consistent neuropathological features resembling mitochondrial disease is a valuable research tool. We have shown 11, 13 that mice lacking the Ndufs4 gene (Ndufs4KO mice) recapitulate the clinical signs of the human disease 9, 13 . Ndufs4KO mice present overt lesions predominantly in the brainstem 11, 13, 29 , but also in the striatum in late stages of the disease 13 . Hence, we hypothesized that a concerted role of diverse neuronal populations was necessary to drive the plethora of symptoms observed in Ndufs4KO mice.
In this study, we use a conditional genetic approach to selectively ablate NDUFS4 in ChATexpressing cholinergic neurons (ChAT:Ndufs4cKO), Vglut2-expressing glutamatergic neurons (Vglut2:Ndufs4cKO) or Gad2-expressing GABAergic neurons (Gad2:Ndufs4cKO), thus restricting
Complex I deficiency to some of the most abundant neuronal populations. This approach allowed us to provide a comprehensive dissection of the neuronal involvement in the phenotype of LS.
Animals lacking Ndufs4 in cholinergic neurons (ChAT:Ndufs4cKO) were phenotypically equivalent to controls, indicating no overt contribution of this cell type to the pathology observed in Ndufs4KO mice. In contrast, Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice had reduced lifespan and body weight, which was accompanied by a decrease in food intake, which are common clinical signs that appear in Leigh Syndrome patients 1, 30 . Recent reports have shown that neuronal cell-specific NDUFS4 knock down in Drosophila also leads to severe feeding abnormalities and premature death 31 . Our results indicate a conserved role for neurons in the onset and progression of the pathological condition of global Ndufs4 deficiency and reveal that both glutamatergic and
GABAergic systems contribute to the growth and lethality phenotype.
Apart from the premature death and feeding deficits, Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice present two markedly distinct clinical entities (summarized in Table 2 ).
With Vglut2:Ndufs4cKO mice, the lethality was associated with severe motor and respiratory alterations, whereas with Gad2:Ndufs4cKO mice, sudden unexpected death was associated with epilepsy (SUDEP) [32] [33] [34] with no overt clinical alteration beyond the weight loss.
Histologically, Vglut2:Ndufs4cKO mice present with prominent neuroinflammation in areas of the brainstem such as the VN, IO and the cerebellar FN, reminiscent of the lesions found in Ndufs4KO mice 11 . We have identified a critical role of brainstem lesions in the development of fatal breathing alterations observed in the Ndufs4KO mice 13 , in agreement with human LS patients 5 .
Glutamatergic signaling in the brainstem has been shown to regulate breathing 35 . In addition, VN glutamatergic neurons have been suggested to modulate respiratory responses 36 . Furthermore, the Pre-Bötzinger (PreBotC) complex, a key respiratory center, is composed of glutamatergic neurons 37 and receives extensive glutamatergic inputs 38 . We have shown that Ndufs4KO mice present intrinsic PreBotC alterations and that vestibular projections to the PreBotC are necessary for maintaining respiration 13 . Our electrophysiological recordings in Vglut2-expressing VN neurons show relatively normal basal firing rate but failure to respond to locomotor activity. Hence, it is likely that failure of glutamatergic VN projections to the PreBotC allowing appropriate responses to physiological needs underlies the breathing deficits observed in Vglut2:Ndufs4cKO mice.
Development of brainstem lesions correlate with motor deficits in animals constitutively lacking Ndufs4 11 . Accordingly, strategies that improve motor symptoms in Ndufs4KO mice, such as AAV-based gene therapy 13, 39 The Gad2-expressing GABAergic neurons do not participate in the appearance of respiratory or motor deficits in Ndufs4 deficiency. However, they are critical for the onset and development of the fatal epileptic seizures that are observed in both global Ndufs4KO mice 11 and LS patients 21, 46 .
Lack of Ndufs4 in Gad2-expressing neurons leads to the appearance of neuroinflammation in the basal ganglia nuclei such as the GPe and SNr. We show that electrophysiological alterations in the GPe neurons predate cortical epileptic events, suggesting a primary role of the basal ganglia circuitry in the development of epileptic seizures in Gad2:Ndufs4cKO mice. Basal ganglia are involved in epilepsy [47] [48] [49] , likely by acting as an inhibitory input to cortical seizure spread via feedback mechanisms 47 . Hence, we hypothesize that basal ganglia inhibitory network is affected in Gad2:Ndufs4cKO mice, being unable to control the activity of cortical excitatory neurons, thus leading to epilepsy. Gad2:Ndufs4cKO mice are resistant to different antiepileptic approaches, such as the widely-used antiepileptic drugs carbamazepine and levetiracetam. Epilepsy-induced death in mitochondrial disease patients is usually linked to refractory epileptic seizures 46 . Hence, Gad2:Ndufs4cKO mice may represent an excellent model to study epileptic mechanisms in LS.
Commonly used antiepileptic drugs may promote mitochondrial toxicity, hindering their use in LS 50 . Therefore, non-conventional antiepileptic interventions, such as rapamycin 51 
Methods

Study approval
All experiments were conducted following the recommendations in the Guide for the Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee of the Seattle Children´s Research Institute and the Universitat Autònoma de Barcelona.
Animal husbandry
Mice were maintained with Teklad Global rodent diet No. 2014S (HSD Teklad Inc., Madison, Wis.) and water available ad libitum in a vivarium with a 12-hour light/dark cycle at 22°C.
Mouse genetics
The following mouse lines were used in this study: Slc17a6 Cre (BAC-Vglut2::Cre) 54 mice were generated by Ole Kiehn. Gad2 Cre/+ (Gad2-IRES-Cre) 55 and Chat Cre/+ (Chat-IRES-Cre) 56 mice were obtained from The Jackson Laboratory (Stock No: 028867 and 031661, respectively) (Bar Harbor, ME). Ndufs4 lox/lox and Ndufs4 '/+ were previously generated by our group 11, 12 . Male and female mice of different ages were used in this study. Sex and age of the animals is described in the figure legends. All mice were on a C57BL/6J background after backcrossing for at least 10 generations. 
Mice with conditional deletion of
Clinical evaluation
Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice were examined every other day for clinical signs resulting from cell type-specific Ndufs4 inactivation. Physiological (body weight) and behavioral (locomotor activity, motor coordination, gait/postural alterations) parameters were evaluated in more than 50 animals for each mouse line and were grouped into the following categories based on visual observation: "+++" severe manifestation of the clinical sign, "++" moderate manifestation of the clinical sign, "+" mild clinical sign, "-" absence of clinical sign. Mice were humanely euthanized after losing 20% of their peak body weight.
Food intake analysis
Food consumption was recorded from 7 to 11 weeks of age using a Physiocage system (Panlab, Spain). Data at 8 weeks of age (right before the median survival value) is presented, including enough individuals to ensure sufficient statistical power.
Behavioral assays
Rotarod test
A standard rotarod device (Rotarod, San Diego Instruments, USA) was used to assess motor and velocity (cm/s) measured using the EthoVision tracking software (Noldus).
Whole-body plethysmography.
Ventilatory function was assessed by whole-body plethysmography (EMMS, England, UK) under unrestrained conditions. The system was calibrated to 1 ml volume. An acclimation period of 45 min was allowed for mice adaptation to the chamber, followed by a 15-min experimental period.
For Vglut2:Ndufs4cKO mice, plethysmography recordings were performed at different stages of the disease (early, n=5; mid, n=7 and late, n=12) according to the clinical examination, and compared to littermate controls (n=12). Studies were also conducted on Gad2:Ndufs4cKO mice (n=7) between 50-60 days of age and compared to corresponding controls (n=7). Respiratory frequency (FR; breaths·minute -1 ) and tidal volume normalized per body weight (VT; PL·g -1 ) were measured.
Tissue preparation
For immunofluorescence, mouse brains were collected and fixed overnight in 4%
paraformaldehyde ( 
Whole-genome gene expression (WGGEX) analysis
For WGGEX analysis, 150 ng of total RNA extracted from the brainstem of Vglut2:Ndufs4cKO (n=4) and Vglut2:Ndufs4cCT mice (n=4) was amplified and biotin-labeled using the Illumina TotalPrep RNA Amplification kit (Ambion). 750 ng of the labeled cRNA was hybridized to
MouseRef-8 v2 expression beadchips (Illumina) for 16 h before washing and analyzing according to the manufacturer's directions. Signal was detected using a BeadArray Reader (Illumina), and data were analyzed for differential expression using the GenomeStudio data analysis software (Illumina). Average normalization, the Illumina custom error model, and multiple testing corrections using the Benjamini and Hochberg false discovery rate were applied to the analysis. Only transcripts with a differential score of >13 (P < 0.05) were considered. Normalized and raw data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (accession number GSE125470). Functional enrichment analysis of differentially expressed mRNAs (1.4 fold or higher) using overrepresentation analysis (ORA) was accomplished using WebGestalt http://www.webgestalt.org) 16 . Characterization of the immune cell composition in these gene expression profiles was accomplished using the computational algorithm ImmuCC 18 .
Surgery
Mice underwent survival surgery to implant EEG and EMG electrodes under isoflurane anesthesia with subcutaneous bupivacaine (1 mg/kg) for analgesia as described 58 . Using aseptic technique, a midline incision was made anterior to posterior to expose the cranium. Each EEG electrode consisted of a micro-screw attached to a fine diameter (130 μm bare; 180 μm coated) silver wire.
The screw electrodes were placed through the small cranial burr holes at visually identified locations: Left and right frontal cortices approximately 1 mm anterior to the bregma and 3 mm lateral of the sagittal suture. EMG electrodes were placed in back muscles. A reference electrode was placed at the midline cerebellum and a ground electrode was placed subcutaneously over the back and the skin was closed with sutures. All electrodes connected to a micro-connector system and their impedances were typically < 10 kΩ. After electrode placement, the skin was closed with sutures and the mice were allowed to recover from surgery for 2-3 days.
Video-EEG-EMG
Recording approach was performed as described 58 . Simultaneous video-EEG-EMG records were collected in conscious mice on a PowerLab 8/35 data acquisition unit using Labchart 7. 
Thermal seizure induction
Mouse body temperature was controlled using a rectal temperature probe and a heat lamp attached to a temperature controller in a feedback loop (Physitemp Instruments Inc., NJ). Briefly, as described 59 , body temperature was increased by 0.5ºC every 2 minutes until seizure occurred or a 42ºC temperature was reached. Mice were immediately cooled using a small fan.
Electrophysiological studies Surgery
Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice and their respective controls (30 to 40 days old)
were anesthetized with 1.5% isoflurane and implanted with a homemade implant in either the vestibular nuclei (AP: -6.0; ML: -1.0; DV: -4.00) or the lateral globus pallidus (AP: -0.46; ML: -1.95;
DV: -4.00), according to Paxinos 57 . Briefly, a small craniotomy window was made above the desired recording site and a 4-tetrode bundle was lowered into the brain until its destination at 0.1 mm/sec (Robot Stereotaxic, Neurostar, Germany). As ground, a stainless steel wire (0.075 mm diameter, Advent Research Material Ltd., England) was placed between skull and dura over the cerebellum or visual cortex. Then the entire implant was attached and secured to animal head with dental cement. After surgery, animal welfare and body weight were documented daily and mice allowed to recover for 10-14 days. In Vglut2:Ndufs4cKO mice and their respective controls, a viral vector expressing the light-sensitive cation channel Channelrodopsin-2 in a Cre-dependent manner (AAV-DIO-ChR2) was delivered into the VN prior to implantation of the tetrode to identify glutamatergic Vglut2-expressing cells after blue light (473 nm) stimulation.
Electrophysiological data acquisition
To explore presence of seizures, the electrophysiological activity was recorded from Gad2:Ndufs4cCT and Gad2:Ndufs4cKO freely moving mice. After the recovery period, animals were placed on a daily basis in an open field arena and both local field potentials (LFPs) and extracellular single-unit activity were recorded until the death of the animal. In Vglut2:Ndufs4cCT and Vglut2:Ndufs4cKO mice, a tetrode bundle was attached along a fiber optic (Ø200 μm Core, 0.22 NA, FG200UCC, Torlabs, USA) to deliver light and record neuronal cells at the same time. 
Electrophysiological data analysis
For the presence of seizures, data were analyzed in Spike2 (Cambridge Electronic Design and Gad2:Ndufs4cCT (n=7) and Gad2:Ndufs4cKO (n=7) mice (E-F). Data are presented as the mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by Bonferroni post-test (*P < 0.05, **P < 0.01, ***P < 0.001). Immune Cell Fraction (%) 
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